Evidence map›Paper›PMID 25044051›Full record

ArticleEuropean neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology2014

The TOMM40 poly-T rs10524523 variant is associated with cognitive performance among non-demented elderly with type 2 diabetes.

Lior Greenbaum, Ramit Ravona Springer, Michael W Lutz, Anthony Heymann, Irit Lubitz, Itzik Cooper, Efrat Kravitz, Mary Sano, Allen D Roses, Jeremy M Silverman and 2 more

Abstract read
In one paragraph

Article in European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. The effects of the TOMM40 poly-T alleles on Alzheimer's disease phenotypes.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2018
    Review
  8. Warning SINEs: Alu elements, evolution of the human brain, and the spectrum of neurological disease.Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology · 2018
    Review
  9. Article
  10. Article
  11. Characterization ofAlzheimer's & dementia (New York, N. Y.) · 2017
    Article
  12. Article
  13. Article
  14. Article
  15. Potential contribution of the Alzheimer's disease risk locus BIN1 to episodic memory performance in cognitively normal Type 2 diabetes elderly.European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · 2016
    Article
  16. Article
  17. The Broad Impact of TOM40 on Neurodegenerative Diseases in Aging.Journal of Parkinson's disease and Alzheimer's disease · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Lior GreenbaumDepartment of Neurology, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel; The Joseph Sagol Neuroscience Center, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel. Electronic address: liorgreenbaum@yahoo.com.
Ramit Ravona SpringerThe Joseph Sagol Neuroscience Center, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel; Memory Clinic, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
Michael W LutzDuke University School of Medicine, Department of Neurology, Durham, NC, USA.
Anthony HeymannDepartment of Family Medicine, University of Tel Aviv, Israel; Maccabi Health Services, Israel.
Irit LubitzThe Joseph Sagol Neuroscience Center, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
Itzik CooperThe Joseph Sagol Neuroscience Center, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
Efrat KravitzThe Joseph Sagol Neuroscience Center, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
Mary SanoDepartment of Psychiatry, Mount Sinai School of Medicine, NY, USA.
Allen D RosesDuke University School of Medicine, Department of Neurology, Durham, NC, USA; Zinfandel Pharmaceuticals Inc., Durham, NC, USA.
Jeremy M SilvermanDepartment of Psychiatry, Mount Sinai School of Medicine, NY, USA.
Ann M SaundersDuke University School of Medicine, Department of Neurology, Durham, NC, USA.
Michal Schnaider BeeriThe Joseph Sagol Neuroscience Center, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel; Department of Psychiatry, Mount Sinai School of Medicine, NY, USA.
Sheba Medical Center · ILIcahn School of Medicine at Mount Sinai · USDuke University · USDurham University · GBTel Aviv University · IL

Funding

VESICULAR LOCALIZATION AND FUNCTION OF PRESENILIN 1 FRAGMENTP50AG005138 · NIA · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI SCHIMMING, CORBETT · 1985 to 2019
$37.9M
Inflammation, long-term diabetes characteristics, and cognitive declineR01AG034087 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SCHNAIDER BEERI, MICHAL · 2009 to 2014
$3.7M
NIA NIH HHS P50 AG005138NIA NIH HHS P50-AG-05138NIA NIH HHS R01 AG034087NIA NIH HHS R01-AG-034087
6 · The paper itself

Abstract

The variable length poly-T, rs10524523 ('523') located within the TOMM40 gene, was recently associated with several phenotypes of cognitive function. The short (S) allele is associated with later AD onset age and better cognitive performance, compared to the longer alleles (long and very-long (VL)). There is strong linkage disequilibrium between variants in the TOMM40 and APOE genes. In this study, we investigated the effect of '523' on cognitive performance in a sample of cognitively normal Jewish elderly with type 2 diabetes, a group at particularly high risk for cognitive impairment. Using a MANCOVA procedure, we compared homozygous carriers of the S/S allele (N=179) to carriers of the VL/VL allele (N=152), controlling for demographic and cardiovascular covariates. The S/S group performed better than the VL/VL group (p=0.048), specifically in the executive function (p=0.04) and episodic memory (p=0.050) domains. These results suggest that previous findings of an association of the TOMM40 short allele with better cognitive performance, independently from the APOE variant status, are pertinent to elderly with diabetes.

Indexed as

Apolipoproteins ECognition DisordersDiabetes Mellitus, Type 2FemaleGenetic Association StudiesGenetic Predisposition to DiseaseGenotypeHumansMaleMembrane Transport ProteinsMitochondrial Precursor Protein Import Complex ProteinsNeuropsychological TestsPolymorphism, Single NucleotideApolipoproteins EMembrane Transport ProteinsMitochondrial Precursor Protein Import Complex ProteinsTOMM40 protein, humanAlzheimer׳s diseaseAPOECognitionTOMM40Type 2 diabetes

Identifiers

PMID25044051
PMCPMC5753419
OpenAlexW2076628639

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.